I just received an email question about whether multiple myeloma survivors should be eating asparagus. So I referred back to a column I wrote a year ago about it. I was surprised and pleased to note that 3,236 people had viewed that post. Pretty cool! I get too busy to keep track of such things.
The prestigious, well known mainstream publication, The Atlantic, included noted cancer research scientist, Harvard Medical School's Jay Bradner, as a part of their Brave Thinkers series. If you recall, Dr. Bradner has been working on the potentially game changing anti-cancer compound, JQ1. Jay Bradner, Research Scientist, Harvard Medical School Two years ago, after Jay Bradner
Two weeks ago I re-visited the promising new anti-cancer therapy, JQ1, after learning that JQ1 may also hold the key to male contraception. If you haven't been following along, last summer a group of Dana-Farber Cancer Institute scientists reported that they had "successfully disrupted the function of a cancer gene involved in the formation of most
A week doesn't go by where I don't hear from a reader asking, "Any news about Dr. Bradner's JQ1? You remember JQ1, don't you? You know, the YouTube sensation that featured the most promising, anti-myeloma drug ever, JQ1? Here are a few links to stories I ran about Dr. James Bradner and JQ1 in the
Yesterday I shared the exciting--if possibly a bit premature--news about the experimental immunotherapy drug, ImMucin. Today, I would like to alert you to another possible major breakthrough in across-the-board cancer therapy: CD47. Although not specifically tested against multiple myeloma, this drug may some day help us--as well as thousands of other solid tumor cancer victims.
Here is an excerpt from another informative article about Dr. James (Jay) Bradner and his research team at Dana-Farber Cancer Institute: Disrupting a cancer gene Novel approach scores first success against elusive cancer gene - HARVARD gazette Scientists at Harvard-affiliated Dana-Farber Cancer Institute have successfully disrupted the function of a cancer gene involved in the
I had a feeling that I might be "stirring things up a bit" when I wrote yesterday's article, New multiple myeloma research video is "smokin' hot"... But is there any real fire there? But the response has been overwhelming. The thing many of you don't realize, is if three comments show-up following a particular blog
If you haven't seen it yet, watch this YouTube video which has gone viral among the multiple myeloma patient community: http://youtu.be/wOiKRVH0nQ8 No question that it is an exciting presentation! But everyone should probably take a step back and calm down a bit. Why? How could I be critical of such a hopeful video? Well, critical
As you know, I usually post information about sub-clinical multiple myeloma therapies on my www.MyelomaNews.com site. But I wanted to share this exciting news from Dana-Farber researchers that I just found posted on HealthCanal.com: Novel Approach Scores First Success Against Elusive Cancer Gene Dana-Farber Cancer Institute scientists have successfully disrupted the function of a cancer